Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies, Expert Rev Anticancer Ther, vol.7, issue.2, pp.169-81, 2007. ,
Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma, Cancer, vol.37, issue.1, pp.1-11, 1976. ,
Osteosarcoma in Korean children and adolescents, Korean J Pediatr, vol.58, issue.4, pp.123-131, 2015. ,
Review of the molecular pathogenesis of osteosarcoma, Asian Pac J Cancer Prev, vol.15, issue.15, pp.5967-76, 2014. ,
Biology of bone sarcomas and new therapeutic developments, Calcif Tissue Int, vol.102, issue.2, pp.174-95, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01653600
Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders, J Am Med Assoc, vol.132, pp.126-158, 1946. ,
Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer, Blood, vol.4, issue.2, pp.160-167, 1949. ,
DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology, Chem Biol, vol.20, issue.5, pp.648-59, 2013. ,
The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma, J Exp Clin Cancer Res, vol.37, issue.1, p.107, 2018. ,
Induction of reactive oxygen species: an emerging approach for cancer therapy, Apoptosis, vol.22, issue.11, pp.1321-1356, 2017. ,
Programmed cell death triggered by nucleotide pool damage and its prevention by MutT homolog-1 (MTH1) with oxidized purine nucleoside triphosphatase, Mutat Res, vol.703, issue.1, pp.51-59, 2010. ,
MTH1 as a nucleotide pool sanitizing enzyme: friend or foe?, Free Radic Biol Med, vol.107, pp.151-159, 2017. ,
Human MTH1 protein hydrolyzes the oxidized ribonucleotide, 2-hydroxy-ATP, Nucleic Acids Res, vol.29, issue.2, pp.449-54, 2001. ,
Oxidative stress: harms and benefits for human health, Oxid Med Cell Longev, p.8416763, 2017. ,
Reactive oxygen species in cancer, Free Radic Res, vol.44, issue.5, pp.479-96, 2010. ,
ROS signalling in the biology of cancer, Semin Cell Dev Biol, vol.80, pp.50-64, 2018. ,
Reactive oxygen species in tumor progression, Front Biosci, vol.10, pp.1881-96, 2005. ,
Addiction to MTH1 protein results in intense expression in human breast cancer tissue as measured by liquid chromatography-isotope-dilution tandem mass spectrometry, DNA Repair, vol.33, pp.101-111, 2015. ,
Oxidative stress and 8-oxoguanine repair are enhanced in colon adenoma and carcinoma patients, Mutagenesis, vol.25, issue.5, pp.463-71, 2010. ,
Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase, Proc Natl Acad Sci, vol.98, issue.20, pp.11456-61, 2001. ,
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool, Nature, vol.508, issue.7495, pp.215-236, 2014. ,
Validation and development of MTH1 inhibitors for treatment of cancer, Ann Oncol, vol.27, issue.12, pp.2275-83, 2016. ,
Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy, Nature, vol.508, issue.7495, pp.222-229, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02168081
Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species, Anticancer Drugs, vol.29, issue.4, pp.341-52, 2018. ,
Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival, Sci Rep, vol.6, p.26521, 2016. ,
Potent and selective inhibitors of MTH1 probe its role in cancer cell survival, J Med Chem, vol.59, issue.6, pp.2346-61, 2016. ,
MTH1 as a chemotherapeutic target: the elephant in the room, Cancers, vol.9, issue.5, 2017. ,
Identification of potent and selective MTH1 inhibitors, Bioorg Med Chem Lett, vol.26, issue.6, pp.1503-1510, 2016. ,
Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis, Bone, vol.94, pp.10-21, 2017. ,
Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence, Proc Natl Acad Sci, vol.106, issue.1, pp.169-74, 2009. ,
Direct detection of 8-oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues, Anal Biochem, vol.255, issue.1, pp.20-31, 1998. ,
Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay, Science, vol.341, issue.6141, pp.84-91, 2013. ,
ATM phosphorylates histone H2AX in response to DNA double-strand breaks, J Biol Chem, vol.276, issue.45, pp.42462-42469, 2001. ,
Genome instability and gam-maH2AX, Int J Mol Sci, vol.18, issue.9, 2017. ,
Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence, Oncogene, vol.30, issue.12, pp.1489-96, 2011. ,
Cancer phenotypic lethality, exemplified by the non-essential MTH1 enzyme being required for cancer survival, Ann Oncol, vol.25, issue.7, pp.1253-1258, 2014. ,
Glioblastoma and glioblastoma stem cells are dependent on functional MTH1, Oncotarget, vol.8, issue.49, pp.84671-84, 2017. ,
Potent and specific MTH1 inhibitors targeting gastric cancer, Cell Death Dis, vol.10, issue.6, p.434, 2019. ,
MTH1 promotes mitotic progression to avoid oxidative DNA damage in cancer cells. bio-Rxiv, p.575290, 2019. ,
MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good?, BMC Cancer, vol.18, issue.1, p.423, 2018. ,
Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures, Sci Rep, vol.9, issue.1, p.819, 2019. ,
The presumed MTH1-inhibitor TH588 sensitizes colorectal carcinoma cells to ionizing radiation in hypoxia, BMC Cancer, vol.18, issue.1, p.1190, 2018. ,
Histone H2A variants H2AX and H2AZ, Curr Opin Genet Dev, vol.12, issue.2, pp.162-171, 2002. ,
Isolation of circulating tumor cells in a preclinical model of osteosarcoma: effect of chemotherapy, J Bone Oncol, vol.12, pp.83-90, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01851614
Prognostic and clinicopathological significance of circulating tumor cells in osteosarcoma, J Bone Oncol, vol.16, p.100236, 2019. ,
hMTH1 is required for maintaining migration and invasion potential of human thyroid cancer cells, DNA Repair, vol.69, pp.53-62, 2018. ,